A contract drug manufacturer (a company that produces medications on behalf of pharmaceutical brands) wants to identify a business model transformation opportunity, not just a manufacturing efficiency gain. Which opportunity should leadership pursue first?

The question asks for a transformation opportunity, which means finding a way to create new value beyond the company's current role. Packaging the manufacturer's accumulated production and quality data into an AI-driven advisory service does exactly that — it converts a byproduct of manufacturing into a standalone offering sold to client brands, shifting the relationship from pure production partner to strategic advisor. Speeding up quality-control paperwork between production runs only makes an existing internal process move faster; the company still just manufactures. Reducing unplanned downtime through earlier predictive-maintenance alerts is a genuine operational win, but it keeps the business exactly where it was — a manufacturer that now runs its floor a bit more smoothly. Improving the accuracy of raw-material forecasts likewise tightens an existing planning process without changing what the company offers or to whom. Three of the four options are internal-efficiency plays, which is a common exam pattern: the correct transformation answer is the one that creates a new offering or a new relationship with clients, not a faster version of the current one. As a check, ask whether client brands would now pay the manufacturer for something beyond physical production — if yes, that's transformation, and if the company is just making the same product more efficiently, that's process improvement.